The new head of the US Food and Drug Administration has inherited an agency battered by crises. Meredith Wadman asks whether Peggy Hamburg can concoct a cure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Frieden, T. R., Fujiwara, P. I., Washko, R. M. & Hamburg, M. A. N. Engl. J. Med. 333, 229-233 (1995).
Graham, D. J. et al. Lancet 365, 475-481 (2005).
Wasman, M. Nature 450, 1143 (2007).
Yeager, A. Nature 457, 770-771 (2009).
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Wadman, M. The FDA: A tough tonic. Nature 462, 406–407 (2009). https://doi.org/10.1038/462406a
Published:
Issue Date:
DOI: https://doi.org/10.1038/462406a